ALS | MG | IN | CCS | P value | |
---|---|---|---|---|---|
No. of patients, n | 43 | 29 | 25 | 13 | |
Female, n (%) | 21 (49%) | 12 (41%) | 9 (36%) | 6 (46%) | 0.779* |
Age (yr), Mean ± SD (range) | 64.9 ± 9.6 (42–78) | 61.7 ± 14.5 (34–83) | 60.6 ± 16.1 (22–80) | 62.5 ± 10.7 (48–81) | 0.554# |
ALS subtype | |||||
Bulbar, n (%) | 11/43 (17%) | - | - | - | - |
Spinal, n (%) | 28/43 (65%) | - | - | - | - |
ALS-FRSR, mean ± SD (range) | 33.6 ± 9.45 (14–48) | - | - | - | - |
MG subtype | |||||
Ocular, n (%) | - | 6/28 (21%) | - | - | - |
Bulbar, n (%) | - | 4/28 (14%) | - | - | - |
Generalized, n (%) | - | 17/28 (61%) | - | - | - |
IN subtypes | |||||
CIDP | - | - | 13/25 (52%) | - | - |
GBS | - | - | 4/25 (16%) | - | - |
MMN | - | - | 4/25 (16%) | - | - |
MADSAM | - | - | 2/25 (8%) | - | - |
AMSAN | - | - | 1/25 (4%) | - | - |
Mononeuritis muliplex | - | - | 1/25 (4%) | - | - |
CCS | |||||
Degree; absolute/high | - | - | - | 7/3 | - |
Myelopathy, n (%) | - | - | - | 10/12 (83%) | - |
Paraspasticity, n(%) | - | - | - | 3/11 (27%) | - |